m.Stock by Mirae AssetOpen Demat Account
m.Stock by Mirae Asset

IPOAvience Biomedicals Ltd IPO

  • Price Range

    ₹196 - ₹208

  • Min. Quantity

    1,200 Shares

  • Closes on

    June 22, 2026

  • Min. investment

    ₹2,49,600

Avience Biomedicals Ltd IPO Timeline

EventDate
Avience Biomedicals Ltd IPO Opening DateJune 18, 2026
Avience Biomedicals Ltd IPO Closing Date June 22, 2026
Basis of AllotmentJune 23, 2026
Initiation of RefundsJune 24, 2026
Credit of Shares to DematJune 24, 2026
Avience Biomedicals Ltd IPO Listing DateJune 25, 2026

Avience Biomedicals Ltd IPO Details

Avience Biomedicals Ltd IPO DateJune 18, 2026 to June 22, 2026
Avience Biomedicals Ltd IPO Face Value₹10 per share
Avience Biomedicals Ltd IPO Price₹196 to ₹208 per share
Avience Biomedicals Ltd IPO Lot Size1,200
Issue Size Shares of ₹10 (aggregating up to ₹30.24 Cr)
Fresh Issue Shares of ₹10 (aggregating up to ₹30.24 Cr)
Offer for Sale-
Issue TypeBook Building - SME
Listing At NSE - SME
QIB Shares OfferedNot more than 2,73,600 of the Net Offer
Retail Shares OfferedNot less than 4,81,200 of the Net Offer
NII (HNI) Shares OfferedNot less than 2,89,200 of the Net Offer
Company PromotersDharam Deo Choudhary, Ram Nagina Choudhary, Janardan Pal

Avience Biomedicals Ltd IPO Lot Size

The Avience Biomedicals Ltd IPO lot size is 1,200 shares. A retail-individual investor can apply for up to 0 lots (0 shares or ₹0).

Application LotsSharesAmount
Minimum11,200₹2,49,600
Maximum-0₹0
  • Risks
  • Opportunities
  • Experienced Management Team and trained Employees.
  • Optimal Utilization of Resources.
  • Quality assurance and control.
  • Cordial relationships with our clients.

Company Financials

Avience Biomedicals Ltd Financial Information (Restated)

Period Ended Total AssetsTotal RevenueProfit After Tax
03-202543.5729.545.00
03-202425.6216.642.00
03-202310.0210.930.78
Amount in ₹ Crore

Objects of the Issue

The company proposes to utilise the Net Proceeds from the Fresh Issue towards funding the following objects:

  • Capital expenditure towards setting up of a new mfg unit at
  • Funding the working capital requirements of the company
  • General corporate purposes

Avience Biomedicals Ltd IPO Promoter Holding

Pre Issue Share Holding50.57%
Post Issue Share Holding37.17%

Avience Biomedicals Ltd IPO Subscription Status (Bidding Detail)

The Avience Biomedicals Ltd IPO is subscribed 355.0575 times on June 22, 2026 05:00:00 PM. The public issue subscribed 401.3566 times in the retail category, 196.7741 times in the QIB category, and 427.7656 times in the NII category. Check Day by Day Subscription Details (Live Status)

CategoryQIBNIIRetailEmployeeTotal
Subscription (times)196.7741427.7656401.3566-355.0575

Avience Biomedicals Ltd IPO Prospectus

Avience Biomedicals Ltd IPO Listing Date

BSE Script
NSE Symbol
Listing In NSE - SME
ISININE0V9I01017
IPO Price₹-
Face Value-

Company Contact Information

Avience Biomedicals Ltd
C-11 Block-C Community CemtreJanakpuri A-3,Delhi-110058
Phone: 1800-12-04-636
Email: info@avienbio.com
Website: www.avienbio.com

Avience Biomedicals Ltd IPO Registrar

Phone:011-40450193-197
Email: ipo@skylinerta.com
Website: www.skylinerta.com

Avience Biomedicals Ltd IPO Lead Manager(s)

  1. Fintellectual Corporate Advisors Pvt Ltd

How to Check the Allotment Status of Avience Biomedicals Ltd IPO?

To check the IPO allotment status, follow these steps:

  • Visit the official website of the IPO registrar.
  • Navigate to the IPO Allotment Status page.
  • Select “Avience Biomedicals Ltd” from the list of available IPOs.
  • Enter any one of these - PAN Number, Application Number, DP/Client ID.
  • Click on Submit to view your allotment status.
  • Alternatively, you can also check the allotment status on the stock exchange websites such as NSE or BSE.
  • About Avience Biomedicals Ltd IPO

    Avience Biomedicals Limited was originally incorporated as Private Limited Company as 'Avience Biomedicals Private Limited' on December 23, 2019 with the Registrar of Companies, Delhi. Later, Company's status got converted into a Public Limited Company, the name of the Company was changed to 'Avience Biomedicals Limited' and fresh Certificate of incorporation dated September 3, 2024, was issued by the Registrar of Companies, Delhi.

    IPOs for Subscription

  • FAQ